SCHEMBL2027273

SCHEMBL2027273

CCCCOC(=O)C(C)NC(C)=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.52
NPSR1 Q6W5P4 1/20 0.46
ATM Q13315 1/20 0.44
ALPG P10696 1/20 0.43
PPARG P37231 1/20 0.43
HTT P42858 1/20 0.43
NCOA2 Q15596 1/20 0.43
NCOA1 Q15788 1/20 0.43
PLA2G2C Q5R387 1/20 0.42
HPGD P15428 3/20 0.41
RECQL P46063 1/20 0.41
ACACB O00763 1/20 0.41
TSHR P16473 3/20 0.41
GAA P10253 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
EPHX1 P07099 1/20 0.40
ACHE P22303 4/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12357211 1.00 ALDH1A1 (0.52) ALDH1A1NPSR1ATMALPGPPARG
SCHEMBL11676262 0.93 PLA2G2C (0.51) PLA2G2CTSHREPHX1ACHE
SCHEMBL11675758 0.93 PLA2G2C (0.51) PLA2G2CTSHREPHX1ACHE
SCHEMBL11675762 0.93 PLA2G2C (0.51) PLA2G2CTSHREPHX1ACHE
SCHEMBL11676258 0.93 PLA2G2C (0.51) PLA2G2CTSHREPHX1ACHE
SCHEMBL5813330 0.88 GAA (0.43) ALDH1A1NPSR1PLA2G2CACACBTSHR
SCHEMBL5813322 0.88 GAA (0.43) ALDH1A1NPSR1PLA2G2CACACBTSHR
SCHEMBL11983353 0.85 ALDH1A1 (0.47) ALDH1A1NPSR1ATMALPGPPARG
SCHEMBL28291958 0.85 ALDH1A1 (0.47) ALDH1A1NPSR1ATMALPGPPARG
SCHEMBL17991466 0.83 ALDH1A1 (0.45) ALDH1A1NPSR1ATMALPGPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118695840-A UV filter composition comprising closed cell metal oxide particles 巴斯夫欧洲公司 2024-09-24 CN disclosed
CN-118574599-A UV filter compositions comprising hybrid metal oxide particles 巴斯夫欧洲公司 2024-08-30 CN disclosed
US-20240033189-A1 METHOD FOR PRODUCING A PERSONALIZED COSMETIC PREPARATION BASF SE (DE) 2024-02-01 US disclosed
US-20230240432-A1 METHOD FOR PRODUCING PERSONALIZED COSMETICS BASF SE (DE) 2023-08-03 US disclosed
EP-3630296-B1 USE OF CERTAIN POLYMERS TO INVOKE AN ANTI-POLLUTION EFFECT BASF SE (DE) 2023-08-02 EP disclosed
WO-2023117874-A1 ENVIRONMENTAL ATTRIBUTES FOR COSMETIC INGREDIENTS BASF SE (DE) 2023-06-29 WO disclosed
CN-115916143-A Biodegradable UV absorbers 巴斯夫欧洲公司 2023-04-04 CN disclosed
CN-115279334-A Anti-aging care compositions comprising perfume 巴斯夫欧洲公司 2022-11-01 CN disclosed
CN-115210215-A Bradyltetracycline amino acid analogs and their use as sunscreens 巴斯夫欧洲公司 2022-10-18 CN disclosed
WO-2022191203-A1 AEROSOL RAW MATERIAL COMPOSITION, AEROSOL COMPOSITION, AND AEROSOL PRODUCT AGC株式会社 2022-09-15 WO disclosed
EP-1814513-A1 PULVERULENT COSMETIC FORMULATION HAVING A HIGH WATER CONTENT Degussa GmbH (DE) 2007-08-08 EP disclosed
US-20070166270-A1 Emulsifier concentrate for a cosmetic composition COGNIS IP MANAGEMENT GMBH (DE) 2007-07-19 US disclosed
US-20070081959-A1 Cosmetic oligo-alpha-olefin containing compound COGNIS IP MANAGEMENT GMBH (DE) 2007-04-12 US disclosed
US-20060275234-A1 Poly-alpha-olefin -containing cosmetic composition COGNIS IP MANAGEMENT GMBH (DE) 2006-12-07 US disclosed
WO-2006056377-A1 PULVERULENT COSMETIC FORMULATION HAVING A HIGH WATER CONTENT DEGUSSA GMBH (DE) 2006-06-01 WO disclosed
US-20060008482-A1 Oil phases for cosmetic agents COGNIS DEUTSCHLAND GMBH & CO. KG (DE) 2006-01-12 US disclosed
US-20050220826-A1 For treating skin and/or hair COGNIS IP MANAGEMENT GMBH (DE) 2005-10-06 US disclosed
US-20050089497-A1 Emollients and cosmetic compositions COGNIS IP MANAGEMENT GMBH (DE) 2005-04-28 US disclosed
US-20050019353-A1 Emollients and cosmetic compositions COGNIS IP MANAGEMENT GMBH (DE) 2005-01-27 US disclosed
US-20040142009-A1 Emollients and cosmetic preparations COGNIS IP MANAGEMENT GMBH (DE) 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230240432-A1 METHOD FOR PRODUCING PERSONALIZED COSMETICS CUTA, TYR, SUCLG1 ALDH1A1 85/4885NPSR1 1729/4885ATM 2483/4885
US-20240033189-A1 METHOD FOR PRODUCING A PERSONALIZED COSMETIC PREPARATION CUTA, NISCH, TYR ALDH1A1 476/4885NPSR1 2551/4885ATM 2154/4885
US-20050089497-A1 Emollients and cosmetic compositions PHOSPHO1, ERCC1, CUTA ALDH1A1 359/4885NPSR1 4379/4885ATM 1032/4885
US-20050019353-A1 Emollients and cosmetic compositions ERCC1, DSG1, PHOSPHO1 ALDH1A1 479/4885NPSR1 4147/4885ATM 1021/4885
US-20040142009-A1 Emollients and cosmetic preparations H1-10, H1-0, RER1 ALDH1A1 63/4885NPSR1 1888/4885ATM 2341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.